Photobiomodulation: using light to treat Alzheimer's disease
• In Montpellier, REGEnLife aims to use light to treat mild to moderate forms of Alzheimer's disease.
• The neurotechnology start-up is currently conducting a clinical trial to validate the efficacy of a medical device that simultaneously stimulates the brain and gut using different light sources: LEDs and lasers in red and near-infrared spectrums.
• The helmet developed by the company could also be used for the treatment of concussion, a common injury in certain contact sports.
Read the article
